Recombinant Annexin A2 Administration Improves Neurological Outcomes After Traumatic Brain Injury in Mice is a research paper published in Frontiers in Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NINDS NIH HHS
Grant: R01 NS092085
National Institutes of Health
Grant: 5R01NS092085-05
Annexin A2 as a cerebrovascular therapy in traumatic brain injury
FWCI
0.96
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals